US$ 24.59
glutathione and small cell lung cancer A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small Frontiers | A prognostic signature
Description
Higher concentrations deliver more peptide per application but are not always proportionally more effective, since the skins capacity to take up and respond to the peptide has limits

Trx1 is showing good efficacy with no major side effects (unpublished data)

J Oncol Pharmacy Pract

Fatigue: The bodys adjustment to lower food intake and metabolic changes can cause temporary tiredness